SS Innovations International Wins 2026 Surgical Robotics Industry Outstanding Company Award

SS Innovations International (NASDAQ: SSII) was named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, highlighting the growing adoption and impact of its SSi Mantra surgical robotic system, with over 11,700 procedures performed across 14 countries.

DC Metrowire Staff
Healthcare
SS Innovations International Wins 2026 Surgical Robotics Industry Outstanding Company Award

SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes excellence in innovation, commercial success, industry leadership, and positive societal impact. The company attributes the award to the growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities, and cost efficiency.

As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. The company also stated that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. These milestones underscore the system's expanding global footprint and its potential to make robotic surgery more accessible.

The award and the operational metrics highlight SS Innovations' progress in a competitive market. The company's focus on affordability and training addresses key barriers to the adoption of robotic surgery, particularly in underserved regions. By providing a cost-effective alternative to established systems, SSi Mantra could democratize access to advanced surgical care. The inclusion of telesurgeries and pediatric procedures further demonstrates the system's versatility and potential for remote healthcare delivery.

SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at ssinnovations.com.

The full press release can be viewed at https://ibn.fm/XWdRe. For disclaimers and terms of use, please visit http://IBN.fm/Disclaimer.

Blockchain Registration

QR Code for Blockchain Registration